CRDL
NASDAQ · Pharmaceuticals
Cardiol Therapeutics Inc-A
$1.05
+0.06 (+5.54%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,212.4% upside
Low Target
$16.80
Average Target
$24.28
High Target
$33.59
Current Price
$1.05
Current
$1.05
$1.05
Target
$24.28
$24.28
$16.80
$24.28 avg
$33.59
Scenario Analysis
Bear Case
$16.80
1,500.0%
Low target
Base Case
$24.28
+2,212.4%
Avg target
Bull Case
$33.59
+3,099.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.17
-51.6% from high
52-Week Low
$1.09
+-3.7% from low
Target vs 52W High
$24.28
+1,018.9% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |